Sign inGet started

Apple Tree Partners IV, L.P.

Insider CIK 1593440 · CERC Director, 10% owner · STOK 10% owner · AKRO 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AKRO Akero Therapeutics, Inc. J Other2021-06-282021-06-305,830,203— $00SEC↗
STOK Stoke Therapeutics, Inc. J Other2021-06-282021-06-3017,161,713— $00SEC↗
STOK Stoke Therapeutics, Inc. P Buy2020-11-242020-11-25375,000$39.00 $14.63M17,161,713SEC↗
AKRO Akero Therapeutics, Inc. P Buy2020-07-102020-07-14415,000$36.00 $14.94M5,830,203SEC↗
AKRO Akero Therapeutics, Inc. C Conversion deriv2019-06-242019-06-2513,000,000— $00SEC↗
AKRO Akero Therapeutics, Inc. C Conversion deriv2019-06-242019-06-25880,568— $00SEC↗
AKRO Akero Therapeutics, Inc. C Conversion2019-06-242019-06-254,228,764— $04,228,764SEC↗
AKRO Akero Therapeutics, Inc. C Conversion2019-06-242019-06-25286,439— $04,515,203SEC↗
AKRO Akero Therapeutics, Inc. P Buy2019-06-242019-06-25900,000$16.00 $14.40M5,415,203SEC↗
STOK Stoke Therapeutics, Inc. C Conversion deriv2019-06-212019-06-217,617,746— $00SEC↗
STOK Stoke Therapeutics, Inc. C Conversion deriv2019-06-212019-06-212,799,910— $00SEC↗
STOK Stoke Therapeutics, Inc. C Conversion deriv2019-06-212019-06-214,980,168— $00SEC↗
STOK Stoke Therapeutics, Inc. P Buy2019-06-212019-06-211,388,889$18.00 $25.00M16,786,713SEC↗
STOK Stoke Therapeutics, Inc. C Conversion2019-06-212019-06-217,617,746— $012,597,914SEC↗
STOK Stoke Therapeutics, Inc. C Conversion2019-06-212019-06-212,799,910— $015,397,824SEC↗
STOK Stoke Therapeutics, Inc. C Conversion2019-06-212019-06-214,980,168— $04,980,168SEC↗
CERC Cerecor Inc. C Conversion deriv2015-10-202015-10-2016,672,224— $00SEC↗
CERC Cerecor Inc. C Conversion2015-10-202015-10-20595,436— $0595,436SEC↗